Novo Nordisk is partnering with OpenAI to "bring new and better treatment options to patients faster," the Danish drugmaker said Tuesday. "Integrating AI in our everyday work gives us the ability to ...
Novo Nordisk said it would work with ChatGPT maker OpenAI on how to leverage artificial intelligence to discover new drugs, the latest AI partnership in the medical field as healthcare companies seek ...
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results